Clinical Trial: Pompe Disease RWE Long-term Monitoring Program

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07834320) titled 'Pompe Disease RWE Long-term Monitoring Program' on April 19, 2024.

Brief Summary: Evaluate short- and long-term biomarker, motor function, respiratory function and safety with avalglucosidase alfa in IOPD and LOPD patients who switched from other ERT.

Study Start Date: Oct. 01, 2023

Study Type: OBSERVATIONAL

Condition: Pompe Disease

Recruitment Status: RECRUITING

Sponsor: National Taiwan University Hospital

Information provided by (Responsible Party): National Taiwan University Clinical Trial Center, National Taiwan University Hospital

Published by HT Digital Content Services with permission from Health Daily Digest....